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SUMMARY 
 
Forty-eight canine mammary tumours (CMT) diagnosed at the Histopathology Laboratory, Faculty of Veterinary Medicine, 
Universiti Putra Malaysia, were reviewed retrospectively. Two control groups, one comprising all other cases involving female dogs 
and another group comprising only cases of neoplasia involving female dogs diagnosed in the laboratory over the same period of 
time were used for comparisons in this study. Fisher’s exact test and logistic regression were used to determine association between 
the factors and the risk of CMT. Thirty-nine (81.3%) of the tumours were diagnosed as adenocarcinoma, 8.3% (n=4) each, were the 
diagnoses for squamous cell carcinoma and mixed cell tumour. Adenoma had 2.1% (n=1). The prevalence of canine mammary gland 
tumours in this study is 39%. When CMT cases were compared with all other cases, significant association was observed with adult 
dogs (p = 0.032, logistic regression 0.012) and intact dogs (p = 0.009, logistic regression, 0.003). When CMT cases were compared 
with neoplasia cases, significant association was observed with pure breeds (p = 0.025) and intact dogs (p = 0.000034, logistic 
regression 0.00042). This study found that pure breed dogs, intact dogs and older dogs ( > 5years) have higher odds of having CMT 
in Malaysian dog population. 
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INTRODUCTION 
 
Canine mammary tumour (CMT) is the second most 
common neoplasm in dogs and mostly affects female dogs 
(Benjamin et al., 1999). High prevalence of up to 50-70% 
has reported in the United States of America (Kelsey et 
al., 1998; Benjamin et al., 1999; Zuccari et al., 2011). In 
Sweden, 111 dogs are affected per 10,000 dog-years at 
risk (Egenvall et al., 2005), while 205 cases per 100,000 
dogs/year have been reported in the United Kingdom 
(Dobson et al., 2002). In India, 39.9% prevalence has been 
reported (Dhami et al., 2010), while in South Africa, 
tumours of the female reproductive system represent 
10.2% of total tumours affecting female dogs, 80% of 
these are mammary gland tumours (Bastianello, 1983).   
There are several risk factors that are associated with 
the development of this disease in dogs. Exposure to 
ovarian hormones; oestrogen and progesterone 
significantly increase the risk CMT development, as early 
spay in bitches has a protective effect against CMT 
development. Bitches that are spayed before the first 
oestrus have a 0.5% risk of CMT development, while 
those spayed after the first and second oestrus have 8% 
and 26% risk, respectively (Schneider et al.,  1969). The 
peak age for occurrence of CMT is around 8 to 11 years 
(Taylor et al., 1976; Sontas et al., 2011). Mammary gland 
tumours are more common in miniature and toy breeds 
(Sorenmo et al.,  2011) with reported highest 
representation in English Springer Spaniels (Dobson et al., 
2002), Poodle (Mitchell et al., 1974) and Terriers (Sontas 
et al., 2011). Obesity at one year of age or at least a year 
prior to diagnosis has been reported with increased risk 
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for CMT development (Perez Alenza et al., 2000). In the 
same study, dogs fed with homemade food or red meat 
also were at higher risk compared to dogs fed on 
commercial diet. 
At the time of diagnosis, 50% to 86% of the CMT 
are diagnosed malignant (Zuccari et al., 2011; Klopfleisch 
et al., 2011). Metastasis through the blood or lymphatic 
system (Rasotto et al., 2012) mainly to the lungs is one of 
the causes of death in dogs with this disease (Klopfleisch 
et al., 2011). Once the tumour has developed at the 
primary site, there are several factors that can affect 
prognosis and predict overall survival. These include, 
tumour histopathology sub-type, stage of the disease and 
size of the tumour (Philibert et al., 2003; Itoh et al., 2005); 
older age at diagnosis (Perez Alenza et al., 2000); 
presence of metastasis to lungs, lymph nodes or other 
internal organs (Zuccari et al., 2008); as well as the 
expression of selected molecular markers by the tumour 
cells (Macewen et al., 1982; Lavalle et al., 2009). 
CMT is one of the most studied neoplasms of the 
dog in various veterinary institutions but to date, there 
have been limited information on the mammary tumour 
development among local dogs in Malaysia and how far 
they resemble the characteristics reported in other 
geographical regions. The objective of this study is to 
determine the prevalence and risk factors for CMT 
development among the dog population diagnosed at a 
veterinary histopathology laboratory in Malaysia.  
 
MATERIALS AND METHODS 
 
Data retrieval 
 
Mammary gland tumour tissues that were submitted 
between January 2006 and December 2012 to the 
veterinary histopathology laboratory of the Faculty of 
Veterinary Medicine (FVM) in Universiti Putra Malaysia 
(UPM) were reviewed. Four µm sections from the 
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respective tumour tissues embedded in paraffin were 
stained with Hematoxylin and Eosin for routine 
histopathology. 
Clinical information of the dogs was reviewed 
retrospectively from the request forms that were submitted 
to the laboratory upon specimen (tumour biopsy) 
submission. The data include age, sex, breed, neuter 
status, tumour size, the affected gland and the total 
number of glands affected in each dog. The age of dogs 
was categorised into dogs that are less than 5 years and 
those that are 5 years or older due to rarity of CMT in 
young dogs. Dog breeds were categorised based on 
pedigree as pure breeds and local/mix breeds because 
genetic variability is known to affect the occurrence of 
several types of cancer, including CMT. Another breed 
categorisation was based on body size, where dogs are 
placed in large breed (large and giant) or small-sized 
(miniature, small and medium) categories based on 
specific breed characteristics. All female dogs diagnosed 
with any conditions, using biopsy or at post mortem, 
(including neoplasms, excluding mammary gland 
tumours) in the histopathology laboratory, FVM, UPM, 
between January 2006 to December 2012 were selected to 
serve as control group 1 (CG1) for the study.  The dogs in 
CG1 were diagnosed with conditions such as neoplasm, 
gastrointestinal disease, parasitism, bone and 
musculoskeletal disorders; poisoning, inflammatory 
diseases and other conditions. Female dogs diagnosed 
with neoplasia were further sub-grouped as control group 
2 (CG2) for the purpose of statistical analysis where risk 
factors for CMT development among female dogs were 
calculated.  
 
Statistical analysis 
 
Fisher’s exact test was used to determine the 
association between the occurrence of mammary gland 
tumours with age, breed and neuter status of the dogs. 
Logistic regression was performed on the variables that 
were associated with occurrence of CMT in dogs to 
ascertain if their association is really an influential one. 
Odds ratio was computed to determine the distribution of 
odds between categories of age, breed and neuter status 
for the occurrence of canine mammary gland tumours. 
Association is considered significant if p < 0.05 within a 
95% confidence interval. Statistical analysis was 
performed using SPSS, version 20 (IBM Corporation, 
U.S. 1989, 2011). 
 
RESULTS 
 
Distribution of Canine Mammary Gland Tumours 
 
All female dog cases diagnosed at histopathology 
laboratory (n=233) were included in this study with the 
exception of few (n=14) missing data for the selected 
parameters of interest. The number of CMT cases and 
dogs in the control groups are presented in Figure 1.  
 
 
Figure 1. Canine mammary gland tumour cases and 
control groups 1 and 2 (CG1 and CG2)  cases recorded 
per year over the period of study 
 
Forty-eight CMT were available for evaluation. A total of 185 female 
dogs were included into CG1, out of which 75 female dogs diagnosed 
with neoplasia were used again as CG2. The years 2007 and 2011 have 
the highest number of CMT cases per year with 9 cases each, while 2009 
has the lowest number of CMT cases (2) recorded. The average number 
of cases of CMT recorded per year is 6.8 cases per year. 
Figure 2. Age distribution of dogs diagnosed with 
mammary gland tumours  
 
The very young dogs (less than 4 years of age) and very old dogs (more 
than 13 years of age) are the groups with least number of affected dogs, 
while dogs between 7 and 13 years of age have the highest number of 
dogs affected with CMT. 
 
Forty-eight female dogs diagnosed with CMT qualified as 
cases, forty of which were submitted from the Universiti 
Veterinary Hospital (UVH) in UPM while eight were 
submitted by other local veterinary clinics in Malaysia 
through the Veterinary Laboratory Services Unit (VLSU). 
Biopsy samples were submitted for diagnosis in 46 of the 
cases, while 2 were diagnosed on post mortem. 
The prevalence of canine mammary gland tumours 
in female dogs in this study is 39.0%.  Overall, 89.6% 
(n=43) CMT were observed in intact females while the 
remaining 10.4% (n=5) were spayed. The mean age of 
occurrence of mammary gland tumour was 8.66 years (SD 
= ± 3.13), the median was 9 years. The age ranged from 2 
to 16 years. A total of 12.5% of the dogs (n=6) aged less 
than 5 years and 87.5% (n=42) above five years (Figure 
2).   
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Table 1. Summary of associations between selected parameters with the occurrence of CMT 
 
Comparison with all other female dogs 
diagnosed at the laboratory as control (CG1) 
Comparison with female dogs diagnosed with 
other types of neoplasia as control (CG2) 
Host factor Cases           Control p-value Cases           Control p-value 
Breed  size             
                 Small 
            Large 
 
36                
12 
 
143            
42 
 
0.568 
 
35                
13 
 
58                
17 
 
0.517 
Breed pedigree   
 Pure breed 
  Local/mix 
 
40                
8 
 
133            
52 
 
0.138 
 
40                
8 
 
48                
27 
 
0.025 
Age              
              Young 
            Old 
 
5                  
43 
 
48              
137 
 
0.032 
Logistic regression: 
0.012 
 
5                  
43 
 
11                
64 
 
0.590 
Neuter Status 
             Spayed          
         Intact 
 
5                  
43 
 
53              
132 
 
0.009 
Logistic regression: 
0.003 
 
 
5                  
43 
 
32                
43 
 
0.00034 
Logistic regression: 
0.00042 
When cases were compared with control group 1, significant association (chi-square and logistic regression) was observed between old age (> 5 
years) and spayed neuter status with occurrence of mammary tumours in the dogs. When cases were compared with control group 2, significant 
association was observed between breed pedigree (chi-square) and spayed neuter status (chi-square and logistic regression) with the occurrence of 
mammary gland tumours 
 
Pure breed made up 83% (n=40) of the cases, 
comprising Terriers (n=6), Cocker spaniel (n=5), three 
each of Beagles, Doberman, Rottweiler and Shi Tzu. Two 
dogs each of German shepherd, Labrador, Spitz and 
Daschaund. Other breeds (Boxer, Pekingese, Chihuahua, 
Poodle, Pomeranian, Pit bull, Miniature Pinscher, Great 
dane and Tibetan spaniel) had a representative each. 
Sixteen percent of the dogs (n=8) were local/mixed 
breeds.  
Other breeds (Boxer, Pekingese, Chihuahua, Poodle, 
Pomeranian, Pit Bull, Miniature pinscher, Great Dane and 
Tibetan Spaniel) had a representative each. Sixteen 
percent of the dogs (n=8) were local/mixed breeds.. A 
total of 25.0% of the dogs (n=12) were large-sized (dogs 
categorised as large and giant based on specific breed 
characteristics) while 75.0% (n=36) were small-sized 
(miniature, small and medium). Thirty-nine (81.3%) of the 
tumours were diagnosed as adenocarcinoma, 8.3% (n=4) 
each, were the diagnoses for squamous cell carcinoma and 
mixed cell tumour. Adenoma had 2.1% (n=1). Majority, 
whereby forty (83.3%) of the mammary gland tumours 
were equal to or greater than 3cm in diameter, while six 
(12.5%) were recorded less than 3cm. The sizes of two 
tumours (4.0%) were not available in the records. In 
70.8% (n=34) of the tumours involve a single gland, while 
29.2% (n=14) of them with multiple glands involvement. 
The most frequent gland affected is the inguinal mammary 
gland (49.3%, n=35) while the least frequent affected 
gland is cranial thoracic mammary gland (2.7%, n=2). 
 
Influence of host factors on occurrence of CMT 
 
For breed categorisation base on pedigree, this study 
found some level of protection against CMT for local/mix 
compared to pure breeds. Odds of 1.955 (CI 95%, 0.858 – 
4.456) for CMT in pure breeds were seen for cases 
compared to all other cases as control (CG 1), and odds of  
 
2.813 (CI 95%, 1.151 – 6.874) for CMT in pure breeds 
compared to local/mixed were seen for cases compared to 
other cancer cases as control (CG2) (Table 1). For breed 
categorization base on size, slightly higher odds for CMT 
were seen for small breeds. Odds of 1.265 (CI 95%, 0.613 
– 2.607) for CMT were observed for small breeds 
compared to large breeds for cases compared to all other 
cases as control, (CG 1) and odds of 1.370 (CI 95%, 0.590 
– 3.182) for CMT in small breeds for cases compared to 
other cancer cases as control (CG 2) (Table 1). The odds 
of developing CMT in intact bitches were 3.45 (CI 95%, 
1.297 – 9.195) compared to spayed bitches, for cases 
compared to all other cases as control (CG1) and odds of 
6.418 (CI 95%, 2.668 – 18.119) for CMT in intact bitches 
compared to spayed bitches in cases compared to other 
cancer cases as control (Table 1). Young age in dogs (less 
than 5 years) confers a significant level of protection from 
CMT, as older dogs (5 years or more than 5 years) had 
odds of 3.013 (CI 95%, 0.128 – 8.050) for having CMT 
compared to young dogs in cases compared to all other 
cases (CG1) and odds of 1.477 (CI 95%, 0.480 – 4.555) 
for CMT in older dogs compared to young dogs in cases 
compared to other cancer cases as control (CG 2) (Table 
1). 
 
DISCUSSION 
 
This study reports for the first time a retrospective 
evaluation of signalment and histopathology diagnosis of 
CMT diagnosed at a veterinary histopathology laboratory 
in Malaysia. The prevalence of 39.0% in this study is low 
compared to the other reports (Andrade et al., 2010; 
Zuccari et al., 2011). This low prevalence could be due to 
the fact that some of the dogs brought to the UVH (where 
majority of the samples were submitted from) already had 
signs of distant metastasis and the owners will not allow 
for any form of intervention or euthanasia to be done. In 
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some other cases, the dogs are taken home to allow for 
natural death based on the dog owner’s request. The 
prevalence reported here does not represent the true 
population in Malaysia but only pet dogs that most likely 
lived within the Klang Valley and small percentage from 
other states in Peninsular Malaysia. Besides that not all 
dogs diagnosed with mammary gland tumour on 
diagnostic cytology will undergo treatment intervention 
and few may be euthanized if tumours are extensive and 
for this the tumours from these dogs will not be submitted 
for histopathology diagnosis and can affect the true 
prevalence reported in this study.   
The median age of 9 years observed in this study is 
consistent with other reports (Perez Alenza et al., 2000; 
Sarli et al., 2002; Rasotto et al., 2012). The development 
of mammary gland tumours in young dogs is not very 
common, as this study observed only 5 dogs below the age 
of 5 years. Tumour development in young female dogs 
(below 2 years) has been described as rare occurrence 
(Zatloukal et al., 2005). An increase in incidence from 3 
cases among the 6 year old dogs, to 6 cases among the 7 
year old dogs was observed. 10 years old dogs have the 
highest representation in our cases, with 17.6% (n=9) 
which is consistent with the peak age of occurrence 
reported by previous works (Zatloukal et al., 2005). A 
sharp decline in incidence was observed after 13 years, 
with a drop from 4 cases to 1 case each at 14, 15 and 16 
years. The higher odds ratio of CMT for older dogs 
observed in this study is in accordance to published 
reports (Taylor et al., 1976; Sonnenschein et al., 1991; 
Zatloukal et al., 2005).  
The prolonged diestrous phase in the canine 
reproductive cycle enhances the repeated and prolonged 
exposure of ovarian hormones (oestrogen) and especially 
the progesterone and hence pose a risk for mammary 
gland tumour development (Rehm et al., 2007). Spaying 
of bitches before 1 year of age has a protective effect on 
the dogs against mammary gland tumour development 
(Sonnenschein et al., 1991). In the results of this study, 
intact females have odds more than 6 times the odds of 
spayed bitches for developing mammary gland tumours. 
According to two other reports, spaying at less than 2 and 
the half years allows for advantage to prevent 
development of mammary gland tumour (Schneider et al., 
1969; Sorenmo et al., 2000). Spaying of bitches after 4 
years of age has no effect against CMT development or 
behaviour of the tumour (Taylor et al., 1976). Overall, 
exposure of female dogs to ovarian hormones early in life 
significantly contributes to CMT development in the dogs, 
and the risk is proportional to the duration of the exposure 
in the young dogs.  
Canine mammary gland tumour studies comparing 
pure and mixed breed (Perez Alenza et al., 2000; Philibert 
et al., 2003) and breed sizes (Itoh et al., 2005) have been 
previously described. Predominance of small breed dogs 
for tumour development has already been reported (Itoh et 
al., 2005). Pure breed dogs are reported to have a higher 
incidence of CMT compared to mixed breeds. The results 
of this study showed a significant difference in the 
occurrence of CMT between pure breed dogs and 
local/mix breeds and that 84.3% of the dogs were pure 
breed with highest frequency in terriers (11.7%) the same 
as reported by (Sontas et al., 2011), followed by cocker 
spaniels (9.8%). An over representation of pure breeds 
(75.7%) compared to mixed breeds was previously 
reported, although no significant associations was noted 
(Philibert et al., 2003). This could be explained to be due 
to genetic variability that is minimal in the pure breed 
dogs, allowing the inheritance of genetic mutations across 
generations, as opposed to the mixed/local dogs that have 
higher genetic variability. Furthermore, pure breed dogs 
such as German shepherd, Doberman, Daschaund and 
Boxer in this order were reported by the Malaysian 
Kennel Association as the commonest dog breeds that 
Malaysians keep as pets (Wong et al., 1985), and could 
explain why the dogs with CMT in this study were 
predominantly pure breeds. Large breeds have a higher 
incidence of CMT in other dog populations with over 
representation of German shepherd dogs (29.3%) 
(Srivastava et al., 2009) and (36.5%) (Dhami et al., 2010). 
In this study, there was a slight increase in the odds of 
CMT development in small breed dogs compared to large 
breed dogs, although the association was not significant.  
In this study, 29.2% of the cases have multiple 
mammary gland involvement which is less than a report 
on 37.0% multiple gland involvement (Mitchell et al., 
1974). Multiple glands involvement may indicate tumours 
that are highly invasive and likely to have lymph node or 
distant metastasis. Inguinal mammary gland has been 
involved in 50.7% of our cases. It has been reported to be 
the most affected gland in CMT (Mitchell et al., 1974; 
Taylor et al., 1976). It has been suggested that high 
involvement of the inguinal gland is due to its larger 
mammary tissue mass and it remains active after the other 
glands have stopped functioning (Mitchell et al., 1974). 
Majority of the tumours were large and this can be 
speculated that the awareness level for early detection of 
tumours when they are smaller in size is not there among 
Malaysians. Another reason could be that the tumours are 
malignant and grow rapidly upon first detection. Most of 
the tumours in this study were diagnosed malignant, hence 
it could be explained why majority of the tumours are 
large. In several other reports, the size was noted as one of 
the prognostic factor, where small sized tumours tend to 
be more benign than malignant and large tumours are 
associated with reduced survival time upon diagnosis 
(Perez Alenza et al., 2000; Sorenmo et al., 2011). 
According to the World Health Organization staging of 
tumours in domestic animals, tumours that are 3 cm or 
more are placed on tumour stage 2 (T2) and tumour stage 3 
(T3) for clinical staging of CMT. Staging information is 
not entirely available for all the dogs in this study because 
most of the submission was only the primary tumour but 
not including the regional lymph nodes.  
The most common histopathology subtype revealed 
in this study is adenocarcinoma. An incidence of 
adenocarcinoma ranging from 31.7 – 54.0% has been 
reported in several other studies (Philibert et al., 2003; 
Itoh et al., 2005). The incidence of 81.3% in our study is 
more than the reported incidence, and shows that 
adenocarcinoma is the most common CMT affecting dogs 
in this population. The possible explanation for this 
scenario is that most of the tumours that are ressected and 
presented to the histopathology laboratory are those truly 
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needing surgical intervention as compared to reduced 
possibility for local veterinarians to recommend resection 
of mammary masses diagnosed as hyperplasia on 
diagnostic cytology or masses that do not cause a 
significant problem to the dog in terms of cutaneous 
ulceration, varying degree of discharges from the affected 
ducts and pain to the dog. Having said that, one dog in this 
study was diagnosed with adenoma and although it is only 
a single case in this study, this histopathology variant is 
commonly reported in humans and studies on CMT 
elsewhere (Goldschmidt et al.,  2011).  
There are several limitations to this study, including 
i) study population only represents the dogs that are 
diagnosed on histopathology at a veterinary based 
laboratory; ii) the dogs presented could be biased to a 
subpopulation of dogs with owners that are willing to 
subject their dogs for surgical intervention and 
histopathology and may have missed others where pet 
owners may decline further diagnosis; iii) the prevalence 
is not a true figure because the baseline control 
populations are biased for dogs that died or euthanised 
with severe diseases which may not ideally represent a 
good control population for comparison and further 
statistical analysis. Ideally, it is recommended that dogs 
that are presented to the veterinary practices and with 
confirmed diagnosis on histopathology and or diagnostic 
cytology could be useful for such epidemiological studies. 
However, this study has given a good overview of the 
histopathology subtypes and clinical characteristics of the 
dogs that developed mammary gland tumours in a subset 
of population of dogs in Malaysia, where most of the 
findings are consistent with previous reports in other 
geographical regions.  
 
CONCLUSION 
 
Overall, a conclusion can be assigned to this study 
where intact, small-sized and pure breed, with older than 5 
years of age have independently increased odds of CMT 
development. The CMT in Malaysia may represent a 
comparable population for further studies on diagnostic or 
prognostic molecular markers and investigations on new 
therapeutic intervention which can be generalised to the 
canine populations worldwide. 
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